These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 19258656)

  • 1. Biological role of liver X receptors.
    Baranowski M
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
    Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor: a cardinal target for atherosclerosis and beyond.
    Parikh M; Patel K; Soni S; Gandhi T
    J Atheroscler Thromb; 2014; 21(6):519-31. PubMed ID: 24695022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptors as therapeutic targets in metabolism and atherosclerosis.
    Nomiyama T; Bruemmer D
    Curr Atheroscler Rep; 2008 Feb; 10(1):88-95. PubMed ID: 18366990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.
    Xiao L; Xie X; Zhai Y
    Adv Drug Deliv Rev; 2010 Oct; 62(13):1316-21. PubMed ID: 20659512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptors (LXR) as therapeutic targets in dyslipidemia.
    Bełtowski J
    Cardiovasc Ther; 2008; 26(4):297-316. PubMed ID: 19035881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
    Fiévet C; Staels B
    Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic opportunities for liver X receptor modulators.
    Collins JL
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
    Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
    J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nuclear receptor LXR is a glucose sensor.
    Mitro N; Mak PA; Vargas L; Godio C; Hampton E; Molteni V; Kreusch A; Saez E
    Nature; 2007 Jan; 445(7124):219-23. PubMed ID: 17187055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver X receptors (LXRs). Part II: non-lipid effects, role in pathology, and therapeutic implications.
    Jamroz-Wiśniewska A; Wójcicka G; Horoszewicz K; Bełtowski J
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():760-85. PubMed ID: 18063919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The liver X receptors.
    Lala DS
    Curr Opin Investig Drugs; 2005 Sep; 6(9):934-43. PubMed ID: 16187693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3).
    Wada T; Kang HS; Angers M; Gong H; Bhatia S; Khadem S; Ren S; Ellis E; Strom SC; Jetten AM; Xie W
    Mol Pharmacol; 2008 Mar; 73(3):891-9. PubMed ID: 18055760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.
    Green CD; Jump DB; Olson LK
    Endocrinology; 2009 Jun; 150(6):2637-45. PubMed ID: 19228891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
    Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
    Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of LXR.
    Michael LF; Schkeryantz JM; Burris TP
    Mini Rev Med Chem; 2005 Aug; 5(8):729-40. PubMed ID: 16101409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells.
    Cozzone D; Debard C; Dif N; Ricard N; Disse E; Vouillarmet J; Rabasa-Lhoret R; Laville M; Pruneau D; Rieusset J; Lefai E; Vidal H
    Diabetologia; 2006 May; 49(5):990-9. PubMed ID: 16482468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in liver X receptor biology and chemistry.
    Goodwin BJ; Zuercher WJ; Collins JL
    Curr Top Med Chem; 2008; 8(9):781-91. PubMed ID: 18537688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue.
    Laffitte BA; Chao LC; Li J; Walczak R; Hummasti S; Joseph SB; Castrillo A; Wilpitz DC; Mangelsdorf DJ; Collins JL; Saez E; Tontonoz P
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5419-24. PubMed ID: 12697904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis.
    Millatt LJ; Bocher V; Fruchart JC; Staels B
    Biochim Biophys Acta; 2003 Mar; 1631(2):107-18. PubMed ID: 12633677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.